ARCUTIS BIOTHERAPEUTICS, INC. Shares Issued
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) had Shares Issued of 125.59 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-05
- 2026-06-30: Common Stock, Shares, Issued 125.59M shares.
- 2026-03-31: Common Stock, Shares, Issued 125.04M shares.
- 2025-12-31: Common Stock, Shares, Issued 123.33M shares; Common Stock, Shares, Issued as first filed 123.33M shares.
- 2025-09-30: Common Stock, Shares, Issued 120.29M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 125.59M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 125.04M shares 10-Q · filed 2026-05-06 | |
| 2025-12-31 | 123.33M shares 10-Q · filed 2026-08-05 | 123.33M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 120.29M shares 10-Q · filed 2025-10-28 | |
| 2025-06-30 | 119.80M shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 119.14M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 117.85M shares 10-K · filed 2026-02-25 | |
| 2024-09-30 | 117.00M shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 116.48M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 115.51M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 96.79M shares 10-K · filed 2025-02-25 | |
| 2023-09-30 | 61.86M shares 10-Q · filed 2023-11-03 | |
| 2023-06-30 | 61.64M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 61.37M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 61.05M shares 10-K · filed 2024-02-27 | |
| 2022-09-30 | 60.93M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 51.55M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 51.41M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 50.35M shares 10-K · filed 2023-02-28 | 50.35M shares 10-K · filed 2022-02-22 |
| 2021-09-30 | 50.27M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 50.23M shares 10-Q · filed 2021-08-05 | |
| 2021-03-31 | 50.15M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 43.68M shares 10-K · filed 2022-02-22 | |
| 2020-09-30 | 38.22M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 38.19M shares 10-Q · filed 2020-08-11 | |
| 2020-03-31 | 38.15M shares 10-Q · filed 2020-05-12 | |
| 2019-12-31 | 2.88M shares 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |